International Trade in the Times of COVID-19

12:00 PM - 12:55 PM, Monday, June 8, 2020 ・ Track Pacific (originally)
Search General Info
Search Education
Search Partnering Companies
In responding to the COVID-19 pandemic, many governments have placed export and other trade restrictions on medical supplies and resources. There is also renewed scrutiny on the supply chain for medicines, with some countries considering repatriation and onshoring policies. What are the implications for biomedical developers and manufacturers, and how will this trend impact the future of our industry?

Join the panel of industry and trade experts to examine key international policies stemming from COVID-19 that may lead to profound shifts in how we conduct businesses. In addition, the panel will explore how governments can better ensure supply chain integrity and resilience to address current pandemic challenges as well as long-term public health preparedness.
Moderator
photo
Partner
Akin Gump Strauss Hauer & Feld LLP
Speakers
photo
Vice President and Managing Director, Washington, D.C. Office
Asia Society Policy Institute
photo
Vice President, Global Public Policy
Merck
photo
President
Alliance for American Manufacturing
photo
Director, Information and External Relations Division and Spokesman
World Trade Organization (WTO)